Pfizer Inc. (PFE)
NYSE: PFE · Real-Time Price · USD
26.21
+0.04 (0.15%)
At close: Jun 12, 2026, 4:00 PM EDT
26.19
-0.02 (-0.08%)
After-hours: Jun 12, 2026, 7:59 PM EDT

Pfizer Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021
Period Ending
Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Oct '23 Jul '23 Apr '23 Dec '22 Oct '22 Jul '22 Apr '22 Dec '21 Oct '21 Jul '21
Net Income
2,709-1,6403,5512,9032,9734114,481313,128-3,356-2,3662,3405,5555,0018,6459,8767,8793,8508,1715,825
Depreciation & Amortization
1,6131,6871,6621,6251,6181,7911,7551,7311,7361,6701,5601,5731,4871,5191,1831,1751,1871,3351,3411,308
Stock-Based Compensation
27222520120317017727420622012115114810536413528786496293221
Other Adjustments
-2463,488-775-324-5081,415-676-214-657-1,665-513-1,354-429-744116-400-1,879-754-5,408-1,541
Changes in Other Operating Activities
-1,732--36-4,989-1,919-879-3,535-3,336--1,199-3,916-5,507--4,109-2,766-730-6,4185,383
Operating Cash Flow
2,6155,3484,603-5822,3356,7216,714-1,7811,0905,2403,456-1,2081,2128,5825,9748,1706,5415,91410,82911,299
Operating Cash Flow Growth
11.99%-20.43%-31.44%-114.22%28.26%94.27%--10.07%-38.94%-42.15%--81.47%45.11%-44.83%-27.69%44.14%5.14%418.13%217.83%
Capital Expenditures
-436-845-602-618-564-917-651-637-704-1,044-810-914-1,139-1,001-841-751-643-1,002-618-537
Purchases of Investments
-2,673-4,127-4,352-3,214-2,957-6,281-2,670-530-832-874-9,206-14,382-6,716-6,969-11,067-10,827-9,434-12,384-11,059-10,001
Proceeds from Sale of Investments
4,6645,3143,0956,6084,0371,5272,1471,06196323,0365,4416,2426,5249,92915,1566,90413,47311,6758,5522,148
Payments for Business Acquisitions
----------43,4050-12.5--16,77200-6,225---
Proceeds from Business Divestments
-0006,3113,549003,491-----------
Other Investing Activities
-770439-5691,172-3,552502-8844,707-1,18711,2905,465-16,4074,64710,402-7,833-6,6403,396-871-6,945256
Investing Cash Flow
785-6,146-2,4303,9513,274-1,623-2,0574,6001,732-10,996888-25,4853,315-4,410-627-11,313567-2,586-10,076-8,137
Short-Term Debt Issued
-1271016-517-3867326725,508-5957,778-128-201237-1,0883664,611-220-361764-474
Short-Term Debt Repaid
-00-151-2,048-3,452-2,922-4,524-328-301-10---1--
Net Short-Term Debt Issued (Repaid)
-1271016-668-2,434-2,720-2,250984-9237,775-128-200236-1,0883664,611-220-360764-474
Long-Term Debt Issued
-2,9840-31.5-00-1,000-1,2500-1,30014,416-269-1,68900-1,609-1,003--
Net Long-Term Debt Issued (Repaid)
-2,9840-31.5-00-1,000-1,2500-1,30014,416-269-1,68900-1,609-1,003--
Repurchase of Common Stock
-------------000-2,000---
Net Common Stock Issued (Repurchased)
-------------000-2,000---
Common Dividends Paid
-2,445-2,445-2,444-2,445-2,437-2,380-2,380-2,380-2,372-2,315-2,314-2,315-2,303-2,245-2,245-2,244-2,249-2,189-2,185-2,183
Other Financing Activities
-284-43-38-21-356-14-6-63-386-18-37-140-43675154-501201324101
Financing Cash Flow
-2,856596-2,477-3,196-5,227-5,114-4,636-2,459-4,9315,442-3,77927,174-2,771-5,015-5,7612,520-6,578-3,351-1,101-2,557
Effect of Exchange Rate Changes on Cash and Cash Equivalents
195241-7-299-18-28-1-32-5-2-26-72-66-1-27-375
Net Cash Flow
563-196-301213375-4529343-2,137-3165354751,754-869-487-688529-50-384608
Free Cash Flow
2,1794,5034,001-1,2001,7715,8046,063-2,4183864,1962,646-2,122737,5815,1337,4195,8984,91210,21110,762
Free Cash Flow Growth
23.04%-22.42%-34.01%-358.81%38.32%129.14%-428.77%-44.65%-48.45%--98.76%54.34%-49.73%-31.06%48.04%1.49%545.04%247.39%
FCF Margin
15.08%25.65%24.02%-8.19%12.91%32.67%34.25%-18.20%2.59%28.80%19.61%-16.31%0.39%30.16%22.67%26.74%22.98%20.61%42.48%56.94%
Free Cash Flow Per Share
0.380.790.70-0.210.311.021.06-0.420.070.740.47-0.370.011.320.901.301.020.851.781.90
Levered Free Cash Flow
2,0052,2794,571-1,772-332-1,4364,198-2,416-1,3625,032-4,25913,2863512,7355,20712,1755,8492,36316,05111,243
Unlevered Free Cash Flow
2,1553,7094,574-1,0792,109-95,6296,465-2,410824.91-2,837-2,837-917395.116,3254,8797,5357,6934,14115,31211,980
SEC Filings: 10-K · 10-Q